No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Sunday, March 15, 2026
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Investing

Dividend Aristocrats In Focus: The Clorox Company

by TheAdviserMagazine
1 month ago
in Investing
Reading Time: 6 mins read
A A
Dividend Aristocrats In Focus: The Clorox Company
Share on FacebookShare on TwitterShare on LInkedIn


Updated on January 30th, 2026 by Bob Ciura

Consumer staples stocks are some of the most reliable dividend payers in the stock market. People need staples products for their daily lives, which provides a certain level of demand from year to year.

Demand for everyday products remains steady, even during recessions, which makes it an appealing industry for investors looking for consistent dividends.

This is why there are several consumer staples stocks on the Dividend Aristocrats list, which includes 69 companies in the S&P 500 Index, with 25+ consecutive years of dividend increases.

You can download an Excel spreadsheet of all 69 Dividend Aristocrats (with metrics that matter such as dividend yields and price-to-earnings ratios) by clicking the link below:

 

Dividend Aristocrats In Focus: The Clorox Company

Disclaimer: Sure Dividend is not affiliated with S&P Global in any way. S&P Global owns and maintains The Dividend Aristocrats Index. The information in this article and downloadable spreadsheet is based on Sure Dividend’s own review, summary, and analysis of the S&P 500 Dividend Aristocrats ETF (NOBL) and other sources, and is meant to help individual investors better understand this ETF and the index upon which it is based. None of the information in this article or spreadsheet is official data from S&P Global. Consult S&P Global for official information.

Each year, we review all Dividend Aristocrats individually. The next stock in the series is The Clorox Company (CLX). Clorox has raised its dividend for 48 years in a row.

This article will provide an in-depth review of Clorox’s business model and future outlook.

Business Overview

Clorox started over 100 years ago, with its namesake liquid bleach debuting in 1913. Today, it is a global manufacturer of consumer and professional products that collectively span a wide variety of uses and customers.

The company produces annual revenue in excess of $7 billion and sells its products in over 100 markets.

The company has a highly diverse set of businesses with myriad brands and products within each, providing Clorox with huge global scale.

The company’s largest segment is health and wellness, which is part of the core Cleaning segment. However, Clorox is much more than a cleaner company as it produces food, pet products, charcoal, and various other brands.

The Household segment includes the Glad, Kingsford, Fresh Step, and Renew Life brands. Cleaning products include Clorox, Pine-Sol, and the Clorox Commercial Solutions businesses.

Lifestyle brands include Hidden Valley, Burt’s Bees, and Brita. Lastly, the International segment sells Clorox’s brands around the world.

Clorox posted first quarter earnings on November 3rd, 2025, and results were better than expected on both the top and bottom lines.

Adjusted earnings-per-share came to 85 cents, which was seven cents ahead of estimates. Revenue was down almost 19% year-over-year to $1.43 billion, but did at least beat estimates by $30 million.

Sales were down primarily due to lower shipments related to the company’s ERP transition. Organic sales plunged 17% during the quarter.

The company shipped about two weeks of inventory in the prior quarter to account for this, so it should normalize in the next quarter.

Gross margin came to 41.7% of revenue, down 410 basis points. This was due to higher manufacturing and logistics costs, primarily. Net cash from operations fell 58% to just $93 million.

The company reiterated guidance for this year despite the weak quarter. We’ve cut our estimate to $6.00 in adjusted earnings-per-share on yet another weak quarter in a string of such results.

Growth Prospects

Looking ahead, Clorox has some levers it can pull to continue its growth. The company continuously innovates with product extensions on its current lineup, such as flavors and cross-branding.

It has done those things for a long time and will continue to do so in order to stay competitive.

It is also focusing its mergers and acquisitions on growing companies, focused in the US, and margin-accretive. The company wants to boost domestic growth and margins through acquisitions.

Margin expansion is another longer-term goal for the company.

Clorox sees potential in rebuilding its margins through pricing actions, cost savings, and optimizing its supply chain over the long term.

Clorox is also taking a prudent approach by buying companies with a better margin profile than its existing portfolio, which boosts revenue and margins simultaneously.

We see Clorox producing 5% earnings-per-share growth annually in the coming years as conditions normalize under the assumption that 2026 is likely to be a trough for earnings.

Clorox continues to buy small amounts of growth while focusing on cost savings and reducing the float.

Margins finished last year very strongly, with pricing increases and cost savings combining to boost profitability. We note continued strength in organic sales as a key driver of earnings.

Competitive Advantages & Recession Performance

Clorox has multiple competitive advantages. First, it holds a tremendously strong brand portfolio. As previously mentioned, Clorox products enjoy high market share across the portfolio.

Clorox retains its high industry position through advertising and spends very heavily to maintain that position.

Product marketing is a necessity for consumer products manufacturers and Clorox spends ~10% of its revenue on this each year.

Another advantage of Clorox’s business model is that its products are used by millions of people each day, both in good and bad economies.

There will always be a certain demand for household cleaning products and food, even if the economy is downturned. This allows the company to remain profitable during recessions.

Indeed, Clorox is a strong example of a defensive stock. Its earnings-per-share through the Great Recession are shown below:

2007 earnings-per-share of $3.23
2008 earnings-per-share of $3.24 (0.3% increase)
2009 earnings-per-share of $3.81 (18% increase)
2010 earnings-per-share of $4.24 (11% increase)

As you can see, Clorox increased earnings-per-share each year throughout the recession, including double-digit earnings growth in 2009 and 2010.

Clorox also performed very well during the coronavirus pandemic, as its products saw much higher demand as consumers spent much more time at home.

This demonstrates the company has a very recession-resistant business model and a high level of safety.

Valuation & Expected Returns

We expect Clorox to generate earnings-per-share of $6.00 for fiscal 2025. Based on this, CLX shares trade for a price-to-earnings ratio of 18.2x. This is above our estimate of fair value, which is 20 times earnings.

Therefore, the stock seems undervalued. An expanding P/E multiple could expand annual returns by 1.9%.

Shareholder returns will be further boosted by future earnings-per-share growth, which we estimate at 5% per year.

Finally, Clorox’s 4.5% dividend yield will add to shareholder returns. This leads to total expected returns of 10.5% per year over the next five years.

This is a decent expected rate of return and warrants a hold rating at this time.

Final Thoughts

Clorox is a reliable dividend stock. The company has a leadership position across its product markets, with potential for some growth.

The company should be able to continue its four-decade-long streak of annual dividend raises regardless of the overall economic climate. This makes it a consistent dividend stock for risk-averse income investors.

Thus, the stock is a hold, and investors interested in total return potential could pick up some shares at today’s price.

Additionally, the following Sure Dividend databases contain the most reliable dividend growers in our investment universe:

The Dividend Champions: Dividend stocks with 25+ years of dividend increases, including those that may not qualify as Dividend Aristocrats.
The Dividend Kings: considered to be the ultimate dividend growth stocks, the Dividend Kings list is comprised of stocks with 50+ years of consecutive dividend increases

If you’re looking for stocks with unique dividend characteristics, consider the following Sure Dividend databases:

The major domestic stock market indices are another solid resource for finding investment ideas. Sure Dividend compiles the following stock market databases and updates them monthly:

Thanks for reading this article. Please send any feedback, corrections, or questions to [email protected].



Source link

Tags: AristocratsCloroxCompanydividendFocus
ShareTweetShare
Previous Post

The NYSE Just Took a Big Step Toward Tokenization

Next Post

5 Commodity-Linked Stocks to Buy Amid Debasement Trade

Related Posts

edit post
Monthly Dividend Stock In Focus: Banco Macro

Monthly Dividend Stock In Focus: Banco Macro

by TheAdviserMagazine
March 13, 2026
0

Published on March 13th, 2026 by Bob Ciura Monthly dividend stocks have instant appeal for many income investors. Stocks that...

edit post
4 Things Landlords Are Responsible For When Renting to Tenants

4 Things Landlords Are Responsible For When Renting to Tenants

by TheAdviserMagazine
March 13, 2026
0

In This Article This article is presented by Steadily. Most real estate investors can tell you their ROI down to...

edit post
Dividend Aristocrats In Focus: Essex Property Trust

Dividend Aristocrats In Focus: Essex Property Trust

by TheAdviserMagazine
March 13, 2026
0

Updated on March 13th, 2026 by Nathan Parsh Essex Property Trust (ESS) isn’t necessarily a household name when it comes...

edit post
The Top 9 Canadian Oil Stocks, Ranked In Order

The Top 9 Canadian Oil Stocks, Ranked In Order

by TheAdviserMagazine
March 12, 2026
0

Updated on March 12th, 2026 by Bob Ciura Canadian oil stocks have proven over the past decade that they can...

edit post
Dividend Aristocrats In Focus: Federal Realty Investment Trust

Dividend Aristocrats In Focus: Federal Realty Investment Trust

by TheAdviserMagazine
March 12, 2026
0

Updated on March 12th, 2026 by Nathan Parsh When it comes to dividend growth stocks, the Dividend Aristocrats are the...

edit post
Monthly Dividend Stock In Focus: Bird Construction

Monthly Dividend Stock In Focus: Bird Construction

by TheAdviserMagazine
March 12, 2026
0

Published on March 12th, 2026 by Bob Ciura Monthly dividend stocks have instant appeal for many income investors. Stocks that...

Next Post
edit post
5 Commodity-Linked Stocks to Buy Amid Debasement Trade

5 Commodity-Linked Stocks to Buy Amid Debasement Trade

edit post
BGB Set to List on Kraken

BGB Set to List on Kraken

  • Trending
  • Comments
  • Latest
edit post
Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

Foreclosure Starts are Up 19%—These Counties are Seeing the Highest Distress

February 24, 2026
edit post
Gasoline-starved California is turning to fuel from the Bahamas

Gasoline-starved California is turning to fuel from the Bahamas

February 15, 2026
edit post
7 States Reporting a Surge in Norovirus Cases

7 States Reporting a Surge in Norovirus Cases

February 22, 2026
edit post
Where Is My 2025 Oregon State Tax Refund

Where Is My 2025 Oregon State Tax Refund

February 13, 2026
edit post
2025 Delaware State Tax Refund – DE Tax Brackets

2025 Delaware State Tax Refund – DE Tax Brackets

February 16, 2026
edit post
The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

The Growing Movement to End Property Taxes Continues in Kentucky, And What It Means For Investors

March 2, 2026
edit post
February CPI reading lifts inflation

February CPI reading lifts inflation

0
edit post
Dividend Aristocrats In Focus: Nucor Corporation

Dividend Aristocrats In Focus: Nucor Corporation

0
edit post
How to Calculate Award Redemption Value

How to Calculate Award Redemption Value

0
edit post
KYIV shares jumped 8.4% to .06 on volume nearly 3x averag

KYIV shares jumped 8.4% to $11.06 on volume nearly 3x averag

0
edit post
Why AI and Big Data Cannot Plan an Economy

Why AI and Big Data Cannot Plan an Economy

0
edit post
2 No-Brainer AI Stocks to Buy Right Now

2 No-Brainer AI Stocks to Buy Right Now

0
edit post
2 No-Brainer AI Stocks to Buy Right Now

2 No-Brainer AI Stocks to Buy Right Now

March 15, 2026
edit post
New IRS MATH Act: What It Means for Error Notices and Your Right to Challenge Them

New IRS MATH Act: What It Means for Error Notices and Your Right to Challenge Them

March 15, 2026
edit post
February CPI reading lifts inflation

February CPI reading lifts inflation

March 15, 2026
edit post
My mother was the kindest teacher in her school and the strictest parent in our house — and the gap between the woman her students adored and the woman who raised me is a distance I’ve been trying to measure my entire adult life

My mother was the kindest teacher in her school and the strictest parent in our house — and the gap between the woman her students adored and the woman who raised me is a distance I’ve been trying to measure my entire adult life

March 15, 2026
edit post
Venus Protocol Hit by Code Exploit, Causing Over .7 Million In Losses

Venus Protocol Hit by Code Exploit, Causing Over $3.7 Million In Losses

March 15, 2026
edit post
A tech entrepreneur used AI to help create the first-ever bespoke cancer vaccine for a dog

A tech entrepreneur used AI to help create the first-ever bespoke cancer vaccine for a dog

March 15, 2026
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • 2 No-Brainer AI Stocks to Buy Right Now
  • New IRS MATH Act: What It Means for Error Notices and Your Right to Challenge Them
  • February CPI reading lifts inflation
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.